Pharma Companies’ Sales Reporting Efforts Often Fall Short. A look at why this occurs and how to avoid it in the future.
Introduction Since the time of blockbuster drugs and mirrored sales teams a decade ago, pharmaceutical reps’ access to physicians continues to decline each year. Studies indicate that between 36.5% – 44% of physicians are now being designated as “no access.” Despite this declining access trend, the industry continues to allocate most of its total sales […]
Delivering Customer ValueAccelerating Brand Performance in an Era of Value-based Medicine Delivering exceptional customer value to drive superior customer engagement.Delivering exceptional customer value – we hear about it every day within the circles of sales and marketing, but what does it really mean? Why is it important, and in the end, does it really matter? […]
Data driven commercial analytics from general empirical to granular Today’s machine learning techniques provide us with a solid basis from which to look forward. With the help of machine learning, pharmaceutical managers can start thinking about the next area where one can bring added value to the HCP or patients. Ultimately, one can make predictions […]
Businesses are thirsty for a competitive edge. Harnessing the power of predictive analytics in bringing medicines to market can provide valuable insights to drive that advantage, and when put into practice, can have far reaching implications to the future of life sciences. Predictive analytics in the life sciences industry has long struggled to cope with […]
The terms Real World Evidence (RWE) and Real World Data (RWD) appear more and more in industry discussions and within FDA reports. The pharma industry is embracing RWE and it is quickly becoming the next big thing in industry intelligence. FDA guidelines have been published for using RWE in clinical studies and the FDA is […]